Merkel Cell Carcinoma — Trials

Merkel Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

133 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 51
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 45.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–14 of 14 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06047379	Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis	recruiting	Phase 1 / Phase 2	134	Neonc Technologies, Inc.INDUSTRY	1	Sep 24, 2026	clinicaltrials
NCT06814496	Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors(RABBIT)	recruiting	Phase 1 / Phase 2	30	University of ArizonaOTHER	1	Sep 22, 2026